Quality & Patient Safety

National Quality Indicators

First quarter 2026 quality report for RSK Bedah Lira Medika Bali, published as part of the hospital’s commitment to transparency, accountability, and patient safety.

Public Quality Report

All published indicators have gone through data collection, monitoring, evaluation, and validation processes by the relevant units in line with the hospital’s quality management standards. This publication is intended to help patients, families, partners, and stakeholders understand the hospital’s ongoing quality improvement efforts.

Reporting Period

Q1 2026

Total Indicators

13 Indicators

Prepared On

20 May 2026

The national quality indicator data displayed on the Lira Medika Bali website reflects the hospital’s commitment to transparent, accountable healthcare that is centered on patient safety.

Validation is carried out periodically to ensure the data presented is accurate, consistent, reliable, and objectively reflects the hospital’s service performance.

This quality publication is expected to serve as an accessible source of information for the public, patients, partners, and stakeholders.

Indicator Details

The summaries below are translated from the internal source document and grouped by indicator number, analysis, recommendation, and special note where applicable.

INM-1

Hand Hygiene Compliance

Analysis

Performance showed an improving trend. At the beginning of the year it was still below the standard, then continued to improve and reached the required standard by the end of March 2026. This indicates that the continuous PDSA improvement efforts carried out by IPCN produced results.

Recommendation

Maintain staff compliance in hand hygiene implementation through consistent monitoring and evaluation by IPCN and active support from all unit coordinators.

90.2%83.5%76.7%70.0%Jan 2026Feb 2026Mar 202685.0%85.0%85.0%75.0%80.8%85.2%
Standard
Lira Medika

Chart for INM-1

INM-2

Personal Protective Equipment (PPE) Compliance

Analysis

Performance improved during the first quarter, although it had not yet reached the established standard. Staff were still found removing PPE in ways that did not comply with the SOP.

Recommendation

Continue monitoring staff compliance in the use of PPE.

105.0%93.9%82.8%71.7%Jan 2026Feb 2026Mar 2026100%100%100%76.7%83.1%88.9%
Standard
Lira Medika

Chart for INM-2

INM-3

Patient Identification Compliance

Analysis

Patient identification compliance for this quarter met the target that had been set.

Recommendation

Maintain indicator compliance and continue monitoring.

105.0%101.7%98.3%95.0%Jan 2026Feb 2026Mar 2026100%100%100%100%100%100%
Standard
Lira Medika

Chart for INM-3

INM-4

Response Time for Cesarean Section Surgery

Note

Not applicable because there had been no OB-GYN services through the end of March 2026.

INM-5

Outpatient Waiting Time

Analysis

The outpatient waiting time indicator for this quarter met the target that had been determined.

Recommendation

Maintain indicator compliance and continue monitoring.

105.0%96.7%88.3%80.0%Jan 2026Feb 2026Mar 202685.0%85.0%85.0%100%100%99.6%
Standard
Lira Medika

Chart for INM-5

INM-6

Elective Surgery Delay

Analysis

The elective surgery delay performance for this quarter remained above the established standard value (standard less than or equal to 5%) and showed an upward trend, indicating that improvement efforts still need to be strengthened.

Recommendation

Carry out improvement efforts by coordinating surgery scheduling with the related units.

30.0%20.0%10.0%0%Jan 2026Feb 2026Mar 20265.0%5.0%5.0%21.4%25.0%25.0%
Standard
Lira Medika

Chart for INM-6

INM-7

Doctor Visit Time Compliance

Analysis

Performance showed an increasing trend, rising by 3%, and was already above the minimum standard set by the Ministry of Health.

Recommendation

Maintain the achievement and strive for continued improvement in the following months, or at minimum remain in line with the 80% minimum standard.

90.7%85.5%80.2%75.0%Jan 2026Feb 2026Mar 202680.0%80.0%80.0%82.6%82.0%85.7%
Standard
Lira Medika

Chart for INM-7

INM-8

Critical Laboratory Result Reporting

Analysis

The reporting time for critical laboratory results in the first quarter was in line with the established standard. In March 2026 there were no critical-value results, so assessment for that month was not applicable.

Recommendation

Maintain indicator performance and continue monitoring.

105.0%101.7%98.3%95.0%Jan 2026Feb 2026Mar 2026100%100%100%100%100%
Standard
Lira Medika

Chart for INM-8

INM-9

National Formulary Compliance

Analysis

National formulary compliance in the first quarter of 2026 met the target that had been determined.

Recommendation

Maintain indicator performance and continue monitoring.

104.4%94.6%84.8%75.0%Jan 2026Feb 2026Mar 202680.0%80.0%80.0%99.4%99.4%99.4%
Standard
Lira Medika

Chart for INM-9

INM-10

Compliance with Clinical Pathways

Note

During the first quarter of 2026, there were no cases among the five designated diagnoses: type II diabetes, hypertension, tuberculosis, HIV, and malignancy.

INM-11

Fall Risk Prevention Compliance

Analysis

Compliance with fall-risk prevention efforts in the first quarter met the established standard.

Recommendation

Maintain the achievement and continue monitoring staff compliance in carrying out fall-risk prevention.

105.0%101.7%98.3%95.0%Jan 2026Feb 2026Mar 2026100%100%100%100%100%100%
Standard
Lira Medika

Chart for INM-11

INM-12

Complaint Response Time

Analysis

The first-quarter performance trend improved, with response time exceeding the established minimum standard.

Recommendation

Maintain the achievement and continue monitoring.

105.0%95.0%85.0%75.0%Jan 2026Feb 2026Mar 202680.0%80.0%80.0%97.1%96.5%100%
Standard
Lira Medika

Chart for INM-12

INM-13

Patient Satisfaction

Analysis

The patient satisfaction index achieved or exceeded the established minimum standard.

Recommendation

Maintain the achievement.

97.1589.2681.3773.48Jan 2026Feb 2026Mar 202676.6176.6176.6188.8993.7594.02
Standard
Lira Medika

Chart for INM-13

Note

Patient satisfaction surveys are conducted every month, but reporting is submitted in July and January, or every six months, in accordance with Ministry of Health regulations.

National Quality Indicators | Lira Medika Hospital Bali